Journal of Shandong University (Health Sciences) ›› 2018, Vol. 56 ›› Issue (4): 51-57.doi: 10.6040/j.issn.1671-7554.0.2017.850

Previous Articles    

Rapamycin improved pulmonary artery hypertension via modulating the phenotypes of macrophages

WANG Bo, XUE Jiang, LIU Aihong, ZHAI Ruirui, WANG Yibiao   

  1. Department of Pediatrics, The Second Hospital of Shandong University, Jinan 250013, Shandong, China
  • Published:2022-09-27

Abstract: Objective To study the effect of rapamycin(RAP)modulating macrophage phenotypes on pulmonary artery hypertension(PAH)and the correlated mechanism. Methods Thirty male Sprague-Dawley rats were randomly divided into the control, PAH and PAH+RAP groups, ten in each group. PAH rat model was induced by left pneumonectomy(PE)and monocrotaline(MCT). Five days after PAH model establishment, the control group and the PAH+RAP group received an intramuscular injection of solvent and RAP for thirty days, respectively. The mean pulmonary artery pressure(mPAP)and right ventricular hypertrophy index(RVHI)were measured in each group via the right cardiac catheter. The degrees of macrophages infiltration and the proliferation of pulmonary arteriolar smooth muscle cells 山 东 大 学 学 报 (医 学 版)56卷4期 -王波,等.雷帕霉素调控巨噬细胞表型改善肺动脉高压 \=-were evaluated by immunohistochemistry, the expression of α-SMA protein was detected by Western blotting, and the expression levels of M2 macrophages was detected by immunofluorescence. The expression levels of TNF-α, IL-1, IL-6 and IL-10 mRNA in each group were detected by RT-PCR. Macrophages were cultured in vitro and treated with LPS+INF-γ, IL-4, and LPS+INF-γ+RAP, respectively; the cells were divided into the blank control group, LPS+INF-γ group, IL-4 group, and LPS+INF-γ+RAP group accordingly. The phenotypes of macrophages were detected by flow cytometry, and the mRNA expression levels of the inflammatory factors were dected by RT-PCR. Results PHA rat models were established successfully. The mPAP, RVHI, α-SMA protein expression level, macrophage infiltration degree and mRNA expression levels of inflammatory factors TNF-α, IL-1β, IL-6, and IL-10 in PAH group were higher than those in the control group(all P<0.05). The mPAP, RVHI, α-SMA protein expression level, and mRNA expression levels of inflammatory factors TNF-α, IL-1β, IL-6, and IL-10 in PAH+RAP group were lower than those in PAH group(all P<0.05). The expression level of M2-type macrophages in PAH+RAP group was higher than that in PAH group(P<0.05). CD86 positive macrophages percentage and mRNA expression levels of TNF-α, IL-1β, IL-6, and IL-10 in LPS+INF-γ group were higher than those in the blank control group in vitro(all P<0.05). CD86 positive macrophages percentage and mRNA expression levels of TNF-α, IL-1β, IL-6, and IL-10 in LPS+IFN-γ+RAP group were lower than those in LPS+INF-γ group(all P<0.05). Conclusion PAH occurrence is accompanied with macrophage infiltration and expression level increase of inflammatory factors. RAP improves PAH via reducing inflammatory response partly depending on inducing the macrophages transformation into M2.

Key words: Rapamycin, Pulmonary arterial hypertension, Macrophages, Pulmonary arterial smooth muscle cells, Phenotype transformation, Interleukin-lβ, Interleukin-6

CLC Number: 

  • R574
[1] Desai A, Desouza SA. Treatment of pulmonary hypertension with left heart disease: a concise review[J]. Vasc Health Risk Manag, 2017, 13: 415-420.
[2] Pereira SL, Kummerle AE, Fraga CA, et al. A novel Ca2+ channel antagonist reverses cardiac hypertrophy and pulmonary arteriolar remodeling in experimental pulmonary hypertension[J]. Eur J Pharmacol, 2013, 702(1-3): 316-322.
[3] Alencar AK, Pereira SL, Montagnoli TL, et al. Beneficial effects of a novel agonist of the adenosine A2A receptor on monocrotaline-induced pulmonary hypertension in rats[J]. Br J Pharmacol, 2013, 169(5): 953-962.
[4] 余莉,范志宇,谢亮,等.雷帕霉素逆转大鼠肺动脉高压的作用机制研究[J].中国当代儿科杂志,2015, 17(7):731-735. YU Li, FAN Zhiyu, XIE Liang, et al. Mechanisms for reversal of pulmonary hypertension by rapamycin in rats[J]. Chin J Contemp Pediatr, 2015, 17(7):731-735.
[5] Wang AP, Li XH, Yang YM, et al. A critical role of the mTOR/eIF2α pathway in hypoxia-induced pulmonary hypertension[J]. PLoS One, 2015, 10(6): e0130806. doi: 10.1371/journal.pone.0130806.
[6] Zhu L, Yang T, Li L, et al. TSC1 controls macrophage polarization to prevent inflammatory disease[J]. Nat Commun, 2014, 5: 4696.
[7] Kishimoto Y, Kato T, Ito M, et al. Hydrogen ameliorates pulmonary hypertension in rats by anti-inflammatory and antioxidant effects[J]. J Thorac Cardiovasc Surg, 2015, 150(3): 645-654.
[8] Vaillancourt M, Ruffenach G, Meloche J, et al. Adaptation and remodelling of the pulmonary circulation in pulmonary hypertension[J]. Can J Cardiol, 2015, 31(4): 407-415.
[9] Kiss T, Kovacs K, Komocsi A, et al. Novel mechanisms of sildenafil in pulmonary hypertension involving cytokines/chemokines, MAP kinases and Akt[J]. PLoS One, 2014, 9(8): e104890. doi: 10.1371/journal.pone.0104890.
[10] Vergadi E, Chang MS, Lee C, et al. Early macrophage recruitment and alternative activation are critical for the later development of hypoxia-induced pulmonary hypertension[J]. Circulation, 2011, 123(18): 1986-1995.
[11] Chen T, Yang C, Li M, et al. Alveolar hypoxia-induced pulmonary inflammation: from local initiation to secondary promotion by activated systemic inflammation[J]. J Vasc Res, 2016, 53(5-6): 317-329.
[12] Yeager ME, Reddy MB, Nguyen CM, et al. Activation of the unfolded protein response is associated with pulmonary hypertension[J]. Pulm Circ, 2012, 2(2): 229-240.
[13] Tian W, Jiang X, Tamosiuniene R, et al. Blocking macrophage leukotriene b4 prevents endothelial injury and reverses pulmonary hypertension[J]. Sci Transl Med, 2013, 5(200): 200ra117.
[14] Martinez FO, Sica A, Mantovani A, et al. Macrophage activation and polarization[J]. Front Biosci, 2008, 13: 453-461.
[15] 刘斌,王献民,魏丽,等. 4种肺动脉高压动物模型肺血管重构模式的差异研究[J].中国病理生理杂志, 2008, 24(2): 289-293. LIU Bin, WANG Xianmin, WEI Li, et al. Differentiation of pulmonary vascular remodeling pattern in 4 models of pulmonary hypertension[J]. Chinese Journal of Pathophysiology, 2008, 24(2): 289-293.
[16] Vats D, Mukundan L, Odegaard JI, et al. Oxidative metabolism and PGC-1β attenuate macrophage-mediated inflammation[J]. Cell metabolism, 2006, 4(1): 13-24.
[17] Price LC, Wort SJ, Perros F, et al. Inflammation in pulmonary arterial hypertension[J]. Chest, 2012, 141(1): 210-221.
[18] Hansson GK. Atherosclerosis-an immune disease: the Anitschkov Lecture 2007[J]. Atherosclerosis, 2009, 202(1): 2-10.
[19] Perros F, Dorfmüller P, Montani D, et al. Pulmonary lymphoid neogenesis in idiopathic pulmonary arterial hypertension[J]. Am J Respir Crit Care Med, 2012, 185(3): 311-321.
[20] Sutendra G, Dromparis P, Bonnet S, et al. Pyruvate dehydrogenase inhibition by the inflammatory cytokine TNFα contributes to the pathogenesis of pulmonary arterial hypertension[J]. J Mol Med(Berl), 2011, 89(8): 771-783.
[21] 郑亚国.肺动脉高压免疫炎症机制研究进展[J].中国循环杂志, 2013, 28(6): 469-471.
[22] Antunes MA, Abreu SC, Cruz FF, et al. Effects of different mesenchymal stromal cell sources and delivery routes in experimental emphysema[J]. Respir Res, 2014, 15: 118.
[23] Vergadi E, Chang MS, Lee C, et al. Early macrophage recruitment and alternative activation are critical for the later development of hypoxia-induced pulmonary hypertension[J]. Circulation, 2011, 123(18): 1986-1995.
[24] Ogawa A, Nakamura K, Matsubara H, et al. Prednisolone inhibits proliferation of cultured pulmonary artery smooth muscle cells of patients with idiopathic pulmonary arterial hypertension[J]. Circulation, 2005, 112(12): 1806-1812.
[25] Price LC, Montani D, Tcherakian C, et al. Dexamethasone reverses monocrotaline-induced pulmonary arterial hypertension in rats[J]. Eur Respir J, 2011, 37(4): 813-822.
[26] Ma X, Yao J, Yue Y, et al. Rapamycin reduced pulmonary vascular remodelling by inhibiting cell proliferation via Akt/mTOR signalling pathway down-regulation in the carotid artery-jugular vein shunt pulmonary hypertension rat model[J]. Interact Cardiovasc Thorac Surg, 2017, 25(2): 206-211.
[27] Segura-Ibarra V, Amione-Guerra J, Cruz-Solbes AS, et al. Rapamycin nanoparticles localize in diseased lung vasculature and prevent pulmonary arterial hypertension[J]. Int J Pharm, 2017, 524(1-2): 257-267.
[28] Aghamohammadzadeh R, Zhang YY, Stephens TE, et al. Up-regulation of the mammalian target of rapamycin complex 1 subunit Raptor by aldosterone induces abnormal pulmonary artery smooth muscle cell survival patterns to promote pulmonary arterial hypertension[J]. FASEB J, 2016, 30(7): 2511-2527.
[1] XIANG Yujiao, LIU Qiang, LIU Lu, SHI Yan. Mechanism of abnormal immune response of dendritic cells in immune thrombocytopenia [J]. Journal of Shandong University (Health Sciences), 2022, 60(7): 89-97.
[2] ZHANG Ludan, DING Xiaoling, CUI Shuyue, CHENG Chen, WEI Fulan, DING Gang. Periodontal ligament stem cells regulate the functions of macrophages in vitro [J]. Journal of Shandong University (Health Sciences), 2021, 59(3): 35-40.
[3] JIANG Yong, SONG Jiangang, ZHU Daxia, LIU Lijian. Effects of naringenin on acute lung injury induced by sepsis via regulating the activation of NLRP3 inflammasome in macrophages [J]. Journal of Shandong University (Health Sciences), 2021, 59(1): 14-21.
[4] FU Jieqi, ZHANG Man, ZHANG Xiaolu, LI Hui, CHEN Hong. Molecular mechanism of Toll-like receptor 4 in the aggravation of blood lipid accumulation by inhibiting the peroxisome proliferator-activate receptor γ [J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 24-31.
[5] ZHANG Xiaolu, WANG Lili, CHEN Kaiming, LOU Xianzhi, ZHANG Man. Mechanism of histone deacetylase SIRT1 inhibiting macrophages apoptosis via TLR4 signaling pathway [J]. Journal of Shandong University (Health Sciences), 2020, 58(12): 8-14.
[6] ZHANG Luan, CHEN Ou, LUAN Yun, ZHU Xiaobo, CHEN Yuan, WANG Yibiao. Effects of gemigliptin on the therapeutic effect and inflammatory factors of monocrotaline-induced pulmonary arterial hypertension in rats [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(5): 19-22.
[7] CHEN Yikun, WANG Ketao, WANG Huayang, SHAO Qianqian, TAN Wanye, SONG Xiaobin, QU Xun, WEI Fengcai. Regulatory role of KIF4A in the expression of angiogenesis- associated factors of macrophages [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(1): 39-43.
[8] ZONG Zhaoyun, LI Xia, HAN Zhenlong, WANG Xianteng, GUO Chun, ZHANG Lining, SHI Yongyu. Effect of tumor associated macrophages on the expression of c-Met in hepatocellular carcinoma cells [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(3): 14-18.
[9] LIU Huimin, LIU Deng, LI Xiaoyu, ZOU Shufeng, JIANG Limin, LI Yuhuan. Effect of Lobelia alkaloids on endothelin-1 signal pathway in a rat model of pulmonary arterial hypertension [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2015, 53(8): 1-4.
[10] TANG Mengmeng, JIN Nüwa, LIU Chuanzhen, LIU Kai, CAO Guangqing, WANG He, PANG Xinyan, WU Shuming. Effects of ethyl pyruvate in the treatment of hyperkinetic pulmonary hypertension [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2015, 53(5): 75-80.
[11] FENG Qing, TAN Xiaodong. L161982 influences macrophage subtypes in rats with experimental autoimmune neuritis [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2015, 53(10): 21-25.
[12] HAN Wenjie1, YU Suguo1, CUI Xiangyu2. Effects of N-acetylcysteine on GLP-1 and IL-6 in high-fat-diet rats with insulin resistance [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(6): 12-16.
[13] QIU Huihui1, YE Liping1, WEN Youfeng2, LI Dan1, SONG Jia1. Effects of IL-6 on the expressions of bcl-2,cyclinD1 and VEGF in ovarian cancer cells [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(6): 17-21.
[14] WANG Hao1, LI Xia2, WANG Chao3, LI Guosheng1, GUO Chun1, ZHU Faliang1, ZHANG Lining1, SHI Yongyu1. Role of tumor-associated macrophages in epithelial-mesenchymal transition of human hepatocellular carcinoma cells [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(4): 8-12.
[15] DONG Zhaojing, SHANG Qianwen, GUO Chun, ZHANG Lining, WANG Qun . Effect of PDCD4 siRNA on the lipid accumulation in macrophages#br# [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(4): 18-21.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!